Cargando…

Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation

Two lipid-based nanoformulations have been used to date in clinical studies: lipoplexes and lipid nanoparticles (LNPs). In this study, we prepared small interfering RNA (siRNA)-loaded carriers using lipid components of the same composition to form molecular assemblies of differing structures, and ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Kohei, Onishi, Kohei, Sawaki, Kazuaki, Li, Tianshu, Mitsuoka, Kaoru, Sato, Takaaki, Takeoka, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529365/
https://www.ncbi.nlm.nih.gov/pubmed/28790820
http://dx.doi.org/10.2147/IJN.S136426
_version_ 1783253104210214912
author Kubota, Kohei
Onishi, Kohei
Sawaki, Kazuaki
Li, Tianshu
Mitsuoka, Kaoru
Sato, Takaaki
Takeoka, Shinji
author_facet Kubota, Kohei
Onishi, Kohei
Sawaki, Kazuaki
Li, Tianshu
Mitsuoka, Kaoru
Sato, Takaaki
Takeoka, Shinji
author_sort Kubota, Kohei
collection PubMed
description Two lipid-based nanoformulations have been used to date in clinical studies: lipoplexes and lipid nanoparticles (LNPs). In this study, we prepared small interfering RNA (siRNA)-loaded carriers using lipid components of the same composition to form molecular assemblies of differing structures, and evaluated the impact of structure on cellular uptake and immune stimulation. Lipoplexes are electrostatic complexes formed by mixing preformed cationic lipid liposomes with anionic siRNA in an aqueous environment, whereas LNPs are nanoparticles embedding siRNA prepared by mixing an alcoholic lipid solution with an aqueous siRNA solution in one step. Although the physicochemical properties of lipoplexes and LNPs were similar except for small increases in apparent size of lipoplexes and zeta potential of LNPs, siRNA uptake efficiency of LNPs was significantly higher than that of lipoplexes. Furthermore, in the case of LNPs, both siRNA and lipid were effectively incorporated into cells in a co-assembled state; however, in the case of lipoplexes, the amount of siRNA internalized into cells was small in comparison with lipid. siRNAs in lipoplexes were thought to be more likely to localize on the particle surface and thereby undergo dissociation into the medium. Inflammatory cytokine responses also appeared to differ between lipoplexes and LNPs. For tumor necrosis factor-α, release was mainly caused by siRNA. On the other hand, the release of interleukin-1β was mainly due to the cationic nature of particles. LNPs released lower amounts of tumor necrosis factor-α and interleukin-1β than lipoplexes and were thus considered to be better tolerated with respect to cytokine release. In conclusion, siRNA-loaded nanoformulations effect their cellular uptake and immune stimulation in a manner that depends on the structure of the molecular assembly; therefore, nanoformulations should be optimized before extending studies into the in vivo environment.
format Online
Article
Text
id pubmed-5529365
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55293652017-08-08 Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation Kubota, Kohei Onishi, Kohei Sawaki, Kazuaki Li, Tianshu Mitsuoka, Kaoru Sato, Takaaki Takeoka, Shinji Int J Nanomedicine Original Research Two lipid-based nanoformulations have been used to date in clinical studies: lipoplexes and lipid nanoparticles (LNPs). In this study, we prepared small interfering RNA (siRNA)-loaded carriers using lipid components of the same composition to form molecular assemblies of differing structures, and evaluated the impact of structure on cellular uptake and immune stimulation. Lipoplexes are electrostatic complexes formed by mixing preformed cationic lipid liposomes with anionic siRNA in an aqueous environment, whereas LNPs are nanoparticles embedding siRNA prepared by mixing an alcoholic lipid solution with an aqueous siRNA solution in one step. Although the physicochemical properties of lipoplexes and LNPs were similar except for small increases in apparent size of lipoplexes and zeta potential of LNPs, siRNA uptake efficiency of LNPs was significantly higher than that of lipoplexes. Furthermore, in the case of LNPs, both siRNA and lipid were effectively incorporated into cells in a co-assembled state; however, in the case of lipoplexes, the amount of siRNA internalized into cells was small in comparison with lipid. siRNAs in lipoplexes were thought to be more likely to localize on the particle surface and thereby undergo dissociation into the medium. Inflammatory cytokine responses also appeared to differ between lipoplexes and LNPs. For tumor necrosis factor-α, release was mainly caused by siRNA. On the other hand, the release of interleukin-1β was mainly due to the cationic nature of particles. LNPs released lower amounts of tumor necrosis factor-α and interleukin-1β than lipoplexes and were thus considered to be better tolerated with respect to cytokine release. In conclusion, siRNA-loaded nanoformulations effect their cellular uptake and immune stimulation in a manner that depends on the structure of the molecular assembly; therefore, nanoformulations should be optimized before extending studies into the in vivo environment. Dove Medical Press 2017-07-19 /pmc/articles/PMC5529365/ /pubmed/28790820 http://dx.doi.org/10.2147/IJN.S136426 Text en © 2017 Kubota et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Kubota, Kohei
Onishi, Kohei
Sawaki, Kazuaki
Li, Tianshu
Mitsuoka, Kaoru
Sato, Takaaki
Takeoka, Shinji
Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
title Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
title_full Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
title_fullStr Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
title_full_unstemmed Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
title_short Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
title_sort effect of the nanoformulation of sirna-lipid assemblies on their cellular uptake and immune stimulation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529365/
https://www.ncbi.nlm.nih.gov/pubmed/28790820
http://dx.doi.org/10.2147/IJN.S136426
work_keys_str_mv AT kubotakohei effectofthenanoformulationofsirnalipidassembliesontheircellularuptakeandimmunestimulation
AT onishikohei effectofthenanoformulationofsirnalipidassembliesontheircellularuptakeandimmunestimulation
AT sawakikazuaki effectofthenanoformulationofsirnalipidassembliesontheircellularuptakeandimmunestimulation
AT litianshu effectofthenanoformulationofsirnalipidassembliesontheircellularuptakeandimmunestimulation
AT mitsuokakaoru effectofthenanoformulationofsirnalipidassembliesontheircellularuptakeandimmunestimulation
AT satotakaaki effectofthenanoformulationofsirnalipidassembliesontheircellularuptakeandimmunestimulation
AT takeokashinji effectofthenanoformulationofsirnalipidassembliesontheircellularuptakeandimmunestimulation